"Notably, only 6/23 (26%, 95%CI: 11–49) had detectable anti-N antibodies in response to their infection, compared to 663/812 (82%, 95%CI: 79–84, p-value= <0.001 (Chi-squared) of all participants in the study with previous PCR-confirmed infection having detectable anti-N antibodies."